DNAAF3 Gene Primary ciliary dyskinesia type 2 NGS Genetic Test
Also known as: PCD Type 2, DNAAF3-related Primary Ciliary Dyskinesia
DNAAF3 Gene Primary ciliary dyskinesia type 2 NGS Genetic Test test available at DNA Labs India for ₹20,000. Uses NGS Technology on Blood or Extracted DNA or One drop Blood on FTA Card samples. Results in 3 to 4 Weeks. Free home collection in 300+ cities across India.
🩺 Medically Reviewed By
Dr Pasupathy Arumugam
Consultant Pathologist · Reg: 21521
Last updated: September 7, 2026
Overview
The purpose of this test is to identify pathogenic mutations in the DNAAF3 gene using next-generation sequencing (NGS) technology, enabling definitive diagnosis of Primary Ciliary Dyskinesia type 2, guiding treatment strategies, and facilitating carrier testing for family planning.
- Test Code
- 4774
- Price
- ₹20,000
- Sample Type
- Blood or Extracted DNA or One drop Blood on FTA Card
- Result Time
- 3 to 4 Weeks
- Fasting Required
- No
- Method
- NGS Technology
Primary Ciliary Dyskinesia (PCD) is a rare genetic disorder that affects the respiratory tract, causing chronic respiratory infections, sinusitis, and bronchiectasis. The DNAAF3 gene is one of the genes that have been identified as being involved in PCD. In this blog post, we will discuss the symptoms and diagnosis of PCD type 2, the role of the DNAAF3 gene in PCD, and the cost of NGS genetic DNA testing for this disorder.
Symptoms of PCD Type 2
PCD type 2 is a subtype of PCD that is caused by mutations in the DNAAF3 gene. The symptoms of PCD type 2 are similar to those of other subtypes of PCD and include:
- Chronic cough
- Chronic respiratory infections
- Sinusitis
- Ear infections
- Shortness of breath
- Nasal congestion
- Fatigue
- Pneumonia
- Wheezing
- Difficulty breathing
These symptoms can vary in severity and may worsen over time.
Diagnosis of PCD Type 2
Diagnosis of PCD type 2 can be challenging, as the symptoms are similar to those of other respiratory conditions. A diagnosis of PCD type 2 is typically made based on a combination of clinical symptoms, imaging studies, and genetic testing.
Imaging studies, such as a high-resolution computed tomography (HRCT) scan, can reveal characteristic abnormalities in the respiratory tract that are indicative of PCD. Genetic testing can also be used to confirm a diagnosis of PCD type 2 by identifying mutations in the DNAAF3 gene.
The Role of the DNAAF3 Gene in PCD
The DNAAF3 gene provides instructions for making a protein called axonemal dynein assembly factor 3, which is essential for the proper functioning of cilia. Cilia are hair-like structures that line the respiratory tract and are responsible for clearing mucus and debris from the lungs.
Mutations in the DNAAF3 gene can disrupt the function of cilia, leading to impaired clearance of mucus and debris from the respiratory tract. This can result in chronic respiratory infections, sinusitis, and bronchiectasis, which are characteristic of PCD.
NGS Genetic DNA Test Cost for PCD Type 2
Next-generation sequencing (NGS) genetic DNA testing can be used to identify mutations in the DNAAF3 gene and confirm a diagnosis of PCD type 2. The cost of NGS genetic DNA testing for PCD type 2 in India is approximately INR 20,000.
NGS genetic DNA testing is a highly sensitive and specific diagnostic tool that can provide a definitive diagnosis of PCD type 2. It can also be used to identify carriers of PCD type 2 mutations, which can be helpful for family planning and genetic counseling.
Conclusion
PCD type 2 is a rare genetic disorder that is caused by mutations in the DNAAF3 gene. The symptoms of PCD type 2 are similar to those of other subtypes of PCD and can be challenging to diagnose. NGS genetic DNA testing can be used to confirm a diagnosis of PCD type 2 and is a valuable diagnostic tool for this disorder. The cost of NGS genetic DNA testing for PCD type 2 in India is approximately INR 20,000.
Sample Collection
No specific preparation required. Provide clinical history and undergo genetic counseling if needed.
Method: Venipuncture or blood drop
Laboratory Analysis
Blood sample collected via venipuncture or a blood drop on FTA card by a trained phlebotomist.
Report Delivery
Apply pressure to the puncture site to prevent bleeding. Store sample as per instructions.
Timeline: 3 to 4 Weeks
Patient Instructions
About This Test
Who Should Get This Test
The purpose of this test is to identify pathogenic mutations in the DNAAF3 gene using next-generation sequencing (NGS) technology, enabling definitive diagnosis of Primary Ciliary Dyskinesia type 2, guiding treatment strategies, and facilitating carrier testing for family planning.
How to Prepare
- Ensure proper labeling of sample
- Use sterile collection equipment
- Transport sample at ambient temperature
Doctor's Notes
Reviewed by Dr Pasupathy Arumugam — MBBS, MD (Pathology) · Reg. No. 21521
"This NGS genetic test is essential for confirming PCD type 2 diagnosis, guiding treatment, and enabling family planning through carrier identification."
Last updated: September 7, 2026
Test Parameters & Specifications
Sample Stability
- Hemolyzed or clotted sample
- Insufficient sample volume
- Improperly labeled sample
Understanding Your Results
Pathogenic variant detected
Confirms diagnosis of PCD type 2. Genetic counseling recommended for family planning.
No pathogenic variant detected
PCD type 2 unlikely, but clinical correlation and additional tests may be needed.
Consult a doctor if you experience chronic respiratory symptoms, recurrent infections, or have a family history of PCD.
Limitations
- ⚠May not detect all genetic variants, including deep intronic mutations
- ⚠Requires genetic counseling for interpretation and family planning
Risks & Considerations
- ●Minimal risk from blood draw, such as bruising or infection
Interfering Factors
- ●Contaminated or degraded DNA sample
- ●Hemolyzed blood sample
Frequently Asked Questions
What is Primary Ciliary Dyskinesia type 2?
What are the symptoms of PCD type 2?
How is PCD type 2 diagnosed?
What is the role of the DNAAF3 gene?
What is NGS genetic testing?
What is the cost of the DNAAF3 Gene NGS Genetic Test in India?
Is home sample collection available for this test?
How long does it take to get the test results?
Is this test covered by insurance?
Who should consider taking this test?
What are the risks of this genetic test?
How should I prepare for the test?
Related Tests
SCNN1A Gene Bronchiectasis with or without elevated sweat chloride type 2 NGS Genetic Test
₹20,000Alpha-1-Antitrypsin (AAT) Phenotype Test
₹18,000Pulmonary panel NGS Genetic Test
₹20,000FLCN Gene Pneumothorax, primary spontaneous NGS Genetic Test
₹20,000DNAI1 Gene Primary ciliary dyskinesia type 1 NGS Genetic Test
₹20,000RSPH9 Gene Primary ciliary dyskinesia type 12 NGS Genetic Test
₹20,000Reference Laboratory Services
We serve as a reference laboratory for hospitals and clinics across India. Send samples from your facility with same-day pickup, priority processing, and results delivered through our online portal. Competitive institutional pricing available.
Your Data Privacy
Your medical data is protected under Indian law.
✓ Stored in India: All patient records are stored on servers located in India. No data is transferred outside the country.
✓ DPDP Act Compliant: Under the Digital Personal Data Protection Act 2023, you can request deletion of your records at any time by contacting support.
Book Your Test
Enter your details and we'll connect you within 15 minutes.